Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures
Png ME., Fernandez MA., Achten J., Parsons N., McGibbon A., Gould J., Griffin X., Costa ML.
<jats:sec><jats:title>Aim</jats:title><jats:p> This paper describes the methods applied to assess the cost-effectiveness of cemented versus uncemented hemiarthroplasty among hip fracture patients in the World Hip Trauma Evaluation Five (WHiTE5) trial. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> A within-trial cost-utility analysis (CUA) will be conducted at four months postinjury from a health system (National Health Service and personal social services) perspective. Resource use pertaining to healthcare utilization (i.e. inpatient care, physiotherapy, social care, and home adaptations), and utility measures (quality-adjusted life years) will be collected at one and four months (primary outcome endpoint) postinjury; only treatment of complications will be captured at 12 months. Sensitivity analysis will be conducted to assess the robustness of the results. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> The planned analysis strategy described here records our intent to conduct a within-trial CUA alongside the WHiTE5 trial. </jats:p></jats:sec>